GNH USA

Europe — EMA

Nefopam Venipharm (Nefopam Hydrochloride)

GNH USA supplies Nefopam Venipharm (Nefopam), a non‑opioid analgesic for moderate acute and post‑operative pain. Request a quote for global supply worldwide.

Request sourcing

1
Pack/s

What is Nefopam Hydrochloride?

Nefopam, the active ingredient in Nefopam Venipharm, is a non‑opioid analgesic presented as an injectable solution for intramuscular and intravenous use. It delivers central analgesic effects for the management of moderate acute pain and post‑operative pain in adult patients.

GNH USA supplies Nefopam Venipharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory conformity across markets. The product is manufactured under EU GMP standards and marketed throughout the European Union and widely used in clinical practice.

What is Nefopam Hydrochloride used for?

Nefopam Venipharm is used for managing pain conditions that involve central nociceptive pathways.

- Moderate acute pain: provides effective analgesia for short‑term severe pain episodes. - Post‑operative pain: reduces pain intensity after surgical procedures. - Acute musculoskeletal pain: helps control pain arising from injuries or strains.

What are the side effects of Nefopam Hydrochloride?

Nefopam Venipharm may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate upset stomach. - Dry mouth: reduced salivation. - Sweating: increased perspiration. - Dizziness: sensation of light‑headedness. - Tachycardia: elevated heart rate. - Blurred vision: temporary visual disturbances.

Serious or Rare Side Effects: - Seizures: risk of convulsive episodes, especially in predisposed individuals. - Severe hypotension: sudden drop in blood pressure. - Anaphylaxis: life‑threatening allergic reaction. - Cardiac arrhythmia: irregular heart rhythms. - Hepatic dysfunction: abnormal liver enzyme elevations.

What precautions apply to Nefopam Hydrochloride?

Use Nefopam Venipharm with caution in specific clinical situations.

- Renal impairment: monitor renal function and adjust therapy as needed. - Seizure history: avoid or use only under strict supervision. - Cardiovascular disease: observe blood pressure and heart rate regularly. - Concomitant MAO inhibitors: increased risk of hypertensive crisis. - Pregnancy and lactation: prescribe only when benefit outweighs potential risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Nefopam Hydrochloride interact with?

Nefopam Venipharm can interact with several medication classes.

Major Interactions (Avoid): - MAO inhibitors: may precipitate hypertensive crisis. - SSRIs/SNRIs: risk of serotonin syndrome. - Tricyclic antidepressants: additive serotonergic effects.

Moderate Interactions (Monitor Closely): - Antihypertensives: possible enhanced hypotensive effect. - Anticholinergic drugs: may increase dry‑mouth sensation. - CYP450 inhibitors/inducers: can alter plasma concentrations of nefopam.

Frequently asked questions

What is Nefopam Venipharm used for?+
Nefopam Venipharm is indicated for the relief of moderate acute pain and for managing pain after surgical procedures. It is a non‑opioid analgesic administered by intramuscular or intravenous injection to provide central analgesia in adult patients.
How does nefopam work to relieve pain?+
Nefopam acts by inhibiting the reuptake of serotonin, norepinephrine and dopamine, and by blocking sodium channels. This combination enhances descending inhibitory pathways in the central nervous system and reduces neuronal excitability, resulting in analgesic effects without engaging opioid receptors.
What is the usual dose of Nefopam Venipharm?+
The dosage of Nefopam Venipharm is determined by the prescribing clinician based on the patient’s condition, severity of pain, and route of administration. Healthcare professionals adjust the dose according to clinical guidelines and individual response.
Is Nefopam Venipharm safe during pregnancy or breastfeeding?+
Safety data for nefopam in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by the treating physician.
How do I order Nefopam Venipharm from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.
How does Nefopam compare with other analgesic options?+
Compared with opioid analgesics, nefopam provides effective pain relief without the risk of opioid‑related dependence or respiratory depression. Its multimodal mechanism differs from NSAIDs, offering an alternative for patients who cannot tolerate anti‑inflammatory drugs or who require opioid‑sparing strategies.
What are the storage and handling requirements for Nefopam Venipharm?+
Nefopam Venipharm should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the product in its original packaging until use to maintain stability and potency.
How is Nefopam Venipharm administered?+
The medication is supplied as an injectable solution and can be given either intramuscularly or intravenously. Administration is performed by qualified healthcare personnel, following aseptic technique and the dosage instructions provided by the prescriber.
What are the most serious risks associated with Nefopam Venipharm?+
Serious adverse events include seizures, severe hypotension, anaphylactic reactions, cardiac arrhythmias, and hepatic dysfunction. Patients with a history of seizures, cardiovascular disease, or known hypersensitivity should be closely monitored, and any signs of these reactions require immediate medical attention.
Who should not use Nefopam Venipharm?+
Nefopam Venipharm is contraindicated in patients with known hypersensitivity to nefopam or any excipients, those currently taking monoamine oxidase inhibitors, and individuals with uncontrolled epilepsy or severe cardiac conduction disorders. Clinicians should evaluate each patient’s medical history before prescribing.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Nefopam Hydrochloride
Route
Intramuscular Use , Intravenous Use
Manufacturer
Venipharm
Origin
EU

Related products